Brandinium

Trademark search for:

THERAQUEST

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2011-11-29 — Application filed
  • 2011-12-02 — Application filed
  • 2011-12-05 — Application filed
  • 2011-12-06 — Notice of pseudo mark mailed
  • 2012-03-12 — Approved for pub - principal register
  • 2012-03-12 — Assigned to examiner
  • 2012-03-29 — Assigned to lie
  • 2012-03-30 — Law office publication review completed
  • 2012-04-11 — Attorney/dom.rep.revoked and/or appointed
  • 2012-04-11 — Teas revoke/app/change addr of atty/dom rep received
  • 2012-04-18 — Notification of notice of publication e-mailed
  • 2012-05-08 — Published for opposition
  • 2012-05-08 — Official gazette publication confirmation e-mailed
  • 2012-06-19 — Teas change of correspondence received
  • 2012-07-02 — Assigned to examiner
  • 2012-07-24 — Registered-principal register
  • 2012-08-08 — Automatic update of assignment of ownership
  • 2017-07-24 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2019-03-01 — Cancelled sec. 8 (6-yr)
  • 2019-03-01 — Final status recorded

Owner Information

RELMADA THERAPEUTICS, INC.
BLUE BELL , PA
TheraQuest Biosciences, Inc.
Blue Bell , PA
TheraQuest Biosciences, Inc.
Blue Bell , PA
TheraQuest Biosciences, Inc.
Blue Bell , PA

Correspondent

Gary D. COLBY DILWORTH PAXSON LLP
1500 MARKET STREET, SUITE 3500E
PHILADELPHIA, PA 19103
UNITED STATES

Filing Details

Filing Date:
2011-11-29
Status Date:
2019-03-01
Category:
Pharmaceuticals
Filing Year:
2011

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.